avalglucosidase alfa-ngpt (Nexviazyme)
avalglucosidase alfa-ngpt is an FDA-licensed reference biologic from Genzyme Corporation. Reference exclusivity, biosimilar lineage, and published patents from official FDA Purple Book records.
0
Biosimilars
0
Interchangeables
0
Listed patents
2021
Reference approved
Reference product
Nexviazyme avalglucosidase alfa-ngpt
Genzyme Corporation
- Approved
- Aug 06, 2021
- Marketing
- Rx
- Center
- CDER
- Patents
- None listed
Exclusivity & patent cliffs
Approval, exclusivity, and published-patent expiration dates for avalglucosidase alfa-ngpt, in chronological order.
Reference approval
Approval date of the reference avalglucosidase alfa-ngpt product.
4 yr 11 mo ago
Frequently asked questions
Are there biosimilars approved for avalglucosidase alfa-ngpt (Nexviazyme)?
No 351(k) biosimilars or interchangeable biosimilars referencing avalglucosidase alfa-ngpt are listed in the FDA Purple Book yet.
Explore the full FDA Purple Book
Search every FDA-licensed biologic, biosimilar, and interchangeable with exclusivity timelines and patent records.